Appointed
Henry McPhie
Director
STEX ·
Streamex Corp.
Mr. McPhie and Mr. Lekstrom were appointed as new directors of the Board.
STEX
Streamex Corp.
Saved in this browser
Ready 8-Ks
27
Latest filing
May 04, 2026 23:59 UTC
Top materiality
0.95
Event mix
other_material ×8 · leadership ×6 · debt ×6
Sentiment
11 pos · 0 neg · 16 neu
Executive change
recent →
Recent 8-K filings for STEX
Highest-materiality recent filing
BioSig announces up to $1.1B financing: $100M convertible debentures + $1B equity line for gold tokenization
- Issues $75M first tranche convertible debenture at 96% of par, 4% interest, 24-month maturity; conversion price tied to VWAP with 20% floor and 19.99% exchange cap.
- Second $25M tranche requires SEC registration effectiveness; proceeds to acquire gold bullion and develop Solana-based RWA tokenization platform.
-
Streamex appoints director, revises CEO/Chairman/CIO employment pacts with milestone bonuses
Mitchell Young Williams appointed to board as non-independent director; effective April 28, 2026.
-
StreamEx refutes false S&P IQ report of 89.8M-share lock-up expiry; co-founders sign 1-yr lock-up
Company refutes S&P Capital IQ/MarketScreener post claiming 89,833,535 shares subject to lock-up expiring March 24, 2026; calls it materially inaccurate.
-
Streamex Corp. Appoints Christine Plummer as CFO, Replaces Ferdinand Groenewald
CFO Ferdinand Groenewald resigned effective March 15, 2026, with severance of $112,500 (6 months base salary) and accelerated vesting of RSUs.
-
Streamex appoints former Cantor Fitzgerald CEO Shawn Matthews to Board of Directors
Shawn Matthews appointed as independent director effective March 3, 2026; term until next annual meeting.
-
Streamex appoints Morgan Lekstrom Executive Chairman; repays $38.9M Yorkville debentures
Morgan Lekstrom named Executive Chairman, effective Feb 9, 2026; joins executive leadership team.
-
Streamex terminates $1B SEPA, prepays $50M convertible debentures with 10% premium
Terminated Standby Equity Purchase Agreement with Yorkville; no shares ever sold under the $1B facility.
-
Streamex closes public offering of 13.4M shares for $40.25M gross proceeds
Offered 11,666,667 shares at $3.00/share for ~$35M; overallotment fully exercised adding 1.75M shares.
-
Streamex corrects board classification vote, invalidates prior structure
Proposal 6 to classify board received 15.4M votes for but failed to achieve majority of outstanding voting power as required.
-
StreamEx Corp. issues $25M second tranche convertible debenture to Yorkville
Issued $25M principal convertible debenture to YA II PN (Yorkville) with net proceeds of ~$24M.
-
Streamex acquires 9.9% stake in Empress Royalty for $12.2M at $5.00 STEX premium
Acquired 12.7M Empress shares from Terra Capital in exchange for 2.44M STEX restricted shares.
-
Three directors resign; Streamex appoints Kevin Gopaul, adopts classified board
Three directors (Steven Abelman, Christopher Baer, Anthony Amato) resigned effective 11/18/25; no disagreement cited.
-
Streamex closes $25M convertible debenture; proceeds to purchase physical gold bullion
Issued $25M principal convertible debenture to YA II PN, Ltd.; net proceeds ~$24M (96% of principal).
-
Stockholders approve issuance of 109M shares to acquire Streamex; deal closed
Special meeting reconvened Nov 4, 2025; Acquisition Proposal approved by stockholders.
-
Streamex receives Nasdaq approval for continued listing; special meeting Nov 4 for acquisition vote
Nasdaq formally approved continued listing on Nasdaq Capital Market under ticker STEX.
-
Entered Amendment No. 2 to Secured Convertible Debenture Purchase Agreement with YA II PN, Ltd. (Yorkville) on October 28, 2025.
-
BioSig/Streamex partners with Monetary Metals to tokenize gold with up to 4% annual yield target
Exclusive three-year partnership to tokenize yield-bearing gold products from Monetary Metals' lease and bond programs.
-
Shareholders approved increasing authorized common shares from 200M to 500M (Ninth Certificate of Amendment filed).
-
Issued 3,852,149 shares of common stock at $3.90/share; gross proceeds ~$15.0M.
-
BioSig amends debenture agreement with Yorkville: up to $100M in convertible notes
First secured convertible debenture of $25M, second of $25M, additional up to $50M at mutual agreement.
-
BioSig amends 8-K to provide Streamex business overview, risk factors, and pro forma financials
Streamex generated ~$200,000 revenue in Q1 2025; platform still under development with no tokenized assets launched.
-
Issues $75M first tranche convertible debenture at 96% of par, 4% interest, 24-month maturity; conversion price tied to VWAP with 20% floor and 19.99% exchange cap.
-
BioSig closes share exchange with Streamex; new CEO and Chairman; pivots to RWA tokenization
BioSig completed acquisition of Streamex; Streamex shareholders receive 75% of fully diluted BSGM shares post-approval.
-
BioSig signs share exchange with Streamex; new CEO McPhie, Lekstrom as Chairman
Streamex shareholders initially get 19.9% of BioSig pre-transaction stock; after approval, 75% of fully diluted shares.
Executive changes
Appointed
Morgan Lekstrom
Chairman of the Board
STEX ·
Streamex Corp.
Morgan Lekstrom, co-founder and Chairman of Streamex, was appointed as the Chairman of the Board.
Appointed
Morgan Lekstrom
Director
STEX ·
Streamex Corp.
Mr. McPhie and Mr. Lekstrom were appointed as new directors of the Board.
Appointed
Henry McPhie
Chief Executive Officer
STEX ·
Streamex Corp.
Henry McPhie, co-founder and Chief Executive Officer of Streamex, was appointed the Company’s new Chief Executive Officer.
Departed
Anthony Amato
Chief Executive Officer, President and Chairman of the Board
STEX ·
Streamex Corp.
Anthony Amato, the Company’s Chief Executive Officer, President and Chairman of the Board of Directors of the Company (the “Board”), resigned as Chief Executive Officer, President and Chairman of the Board
Departed
Frederick D. Hrkac
Director
STEX ·
Streamex Corp.
Frederick D. Hrkac resigned from the Board
Departed
Anthony Amato
Other Named Officer
STEX ·
Streamex Corp.
In connection with Mr. Amato’s resignation pursuant to the Share Purchase Agreement, the Company and Mr. Amato expect to enter into (i) a First Amendment to the Executive Employment Agreement (the “First Amendment”) and (ii) a letter agreement (the “Right to Place”).
Materiality & sentiment trend
Max materiality 0.95 · Median 0.70 · Most common event other_material